- Report
- January 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- March 2024
- 192 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- February 2024
- 78 Pages
Global
From €3385EUR$3,500USD£2,901GBP
- Report
- March 2024
- 180 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 188 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 182 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 191 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 193 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 198 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- March 2024
- 187 Pages
Global
From €3263EUR$3,374USD£2,796GBP
€3625EUR$3,749USD£3,107GBP
- Report
- April 2024
- 138 Pages
Global
From €3771EUR$3,899USD£3,231GBP
- Report
- January 2024
- 149 Pages
Global
From €3771EUR$3,899USD£3,231GBP
- Report
- April 2024
- 92 Pages
Global
From €5415EUR$5,600USD£4,641GBP
- Report
- April 2024
- 269 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- February 2024
- 250 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- February 2024
- 175 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- December 2023
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- December 2023
- 200 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- April 2024
- 138 Pages
Global
From €3771EUR$3,899USD£3,231GBP
- Report
- March 2024
- 146 Pages
Global
From €3771EUR$3,899USD£3,231GBP
The Type 2 diabetes market, within the context of diabetes devices, encompasses a range of products designed to monitor and control blood glucose levels, as well as deliver insulin for patients in need of external sources of the hormone. Key devices include blood glucose meters, continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin pens. These devices are essential for patients to manage their condition effectively, helping to reduce the risk of complications associated with diabetes and improving overall quality of life. Advances in technology have led to the development of more accurate, user-friendly, and integrated devices, many of which can connect to smartphone apps and health management platforms to assist in tracking and analyzing diabetic data over time. This integration facilitates better personalized care and more refined treatment plans.
Companies active in the Type 2 diabetes devices market comprise a mix of established pharmaceutical companies and specialized medical device manufacturers. Some notable companies include Medtronic, Abbott Laboratories, Dexcom, Inc., Ascensia Diabetes Care, Insulet Corporation, Tandem Diabetes Care, LifeScan, Inc., and Roche Diabetes Care. These companies are at the forefront of innovation in the diabetes devices sector, investing in research and development to offer advanced solutions that address the needs of those managing Type 2 diabetes. Show Less Read more